Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Toward safer regenerative medicine

A newly identified surface marker on human embryonic stem cells allows rare tumor-forming cells to be removed from preparations of differentiated cells.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1: The carbohydrate structures of SSEA-1, SSEA-3, SSEA-4 and SSEA-5 (refs. 1, 4, 8).

References

  1. Tang, C. et al. Nat. Biotechnol. 29, 829–834 (2011).

    Article  CAS  Google Scholar 

  2. Boyse, E.A. & Old, L.J. Annu. Rev. Genet. 3, 269–290 (1969).

    Article  Google Scholar 

  3. Artzt, K. et al. Proc. Natl. Acad. Sci. USA 70, 2988–2992 (1973).

    Article  CAS  Google Scholar 

  4. Wright, A. & Andrews, P.W. Stem Cell Res. (Amst.) 3, 3–11 (2009).

    Article  CAS  Google Scholar 

  5. Solter, D. & Knowles, B.B. Proc. Natl. Acad. Sci. USA 75, 5565–5569 (1978).

    Article  CAS  Google Scholar 

  6. Adewumi, O. et al. Nat. Biotechnol. 25, 803–816 (2007).

    Article  CAS  Google Scholar 

  7. Enver, T., Pera, M., Peterson, P. & Andrews, P.W. Cell Stem Cell 4, 387–397 (2009).

    Article  CAS  Google Scholar 

  8. Fenderson, B.A., Eddy, E.M. & Hakomori, S. Bioessays 12, 173–179 (1990).

    Article  CAS  Google Scholar 

  9. Natunen, S. et al. Glycobiology 21, 1125–1130 (2011).

    Article  CAS  Google Scholar 

  10. Choo, A.B. et al. Stem Cells 26, 1454–1463 (2008).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Peter W Andrews.

Ethics declarations

Competing interests

I receive payment from the Wistar Institute for a proportion of royalty payments that Wistar receives form the sale of TRA antibodies.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Andrews, P. Toward safer regenerative medicine. Nat Biotechnol 29, 803–805 (2011). https://doi.org/10.1038/nbt.1974

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nbt.1974

This article is cited by

Search

Quick links

Nature Briefing: Translational Research

Sign up for the Nature Briefing: Translational Research newsletter — top stories in biotechnology, drug discovery and pharma.

Get what matters in translational research, free to your inbox weekly. Sign up for Nature Briefing: Translational Research